Compare · ATPC vs OPCH
ATPC vs OPCH
Side-by-side comparison of Agape ATP Corporation (ATPC) and Option Care Health Inc. (OPCH): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ATPC and OPCH operate in Medical/Nursing Services (Health Care), so they compete in similar markets.
- OPCH is the larger of the two at $3.26B, about 1048.5x ATPC ($3.1M).
- Over the past year, ATPC is down 96.1% and OPCH is down 34.8% - OPCH leads by 61.3 points.
- OPCH has been more active in the news (13 items in the past 4 weeks vs 1 for ATPC).
- OPCH has more recent analyst coverage (15 ratings vs 0 for ATPC).
- Company
- Agape ATP Corporation
- Option Care Health Inc.
- Price
- $3.08+1.49%
- $20.79-2.76%
- Market cap
- $3.1M
- $3.26B
- 1M return
- +37.89%
- +6.05%
- 1Y return
- -96.11%
- -34.80%
- Industry
- Medical/Nursing Services
- Medical/Nursing Services
- Exchange
- NASDAQ
- NASDAQ
- IPO
- News (4w)
- 1
- 13
- Recent ratings
- 0
- 15
Option Care Health Inc.
Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides immunoglobulin infusion therapies for the treatment of immune deficiencies; anti-infective therapies and services; home infusion services to treat heart failures; and treatments for chronic inflammatory disorders, including Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders; and immunoglobulin infusion therapies. It also offers infusion therapies for bleeding disorders; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications. In addition, the company offers therapies that women need to survive and thrive through high-risk pregnancies; treatments to manage the progression of neurological disorders, such as amyotrophic lateral sclerosis and duchenne muscular dystrophy; and nursing services. The company is headquartered in Bannockburn, Illinois.
Latest ATPC
- SEC Form S-1 filed by Agape ATP Corporation
- SEC Form 10-Q filed by Agape ATP Corporation
- SEC Form 10-K filed by Agape ATP Corporation
- SEC Form NT 10-K filed by Agape ATP Corporation
- Agape ATP Corporation filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
- Agape ATP Corporation Regains Compliance with Nasdaq Minimum Bid Price Requirement
- Agape ATP Corporation filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits
- AGAPE ATP Corporation Forges Strategic Collaboration with UAE-Based Citadel Investment
- SEC Form S-3 filed by Agape ATP Corporation
- Agape ATP Corporation filed SEC Form 8-K: Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Regulation FD Disclosure, Financial Statements and Exhibits
Latest OPCH
- Goldman initiated coverage on Option Care Health with a new price target
- Option Care Health Appoints Robert Okunski as Vice President, Investor Relations
- Option Care Health Awarded TIME's World's Most Impactful Companies 2026 Ranking
- Director Bierbower Elizabeth D was granted 8,997 shares, increasing direct ownership by 38% to 32,871 units (SEC Form 4)
- Director Deckmann Natasha was granted 9,841 shares, increasing direct ownership by 44% to 32,002 units (SEC Form 4)
- Director Kraemer Harry M Jansen Jr was granted 21,076 shares, increasing direct ownership by 5% to 471,076 units (SEC Form 4)
- Director Pate R Carter was granted 8,997 shares, increasing direct ownership by 77% to 20,620 units (SEC Form 4)
- Director Sullivan Timothy P was granted 13,833 shares, increasing direct ownership by 19% to 87,216 units (SEC Form 4)
- Director Bodem Barbara W. was granted 8,997 shares, increasing direct ownership by 74% to 21,087 units (SEC Form 4)
- Director Wright Norman L. was granted 8,997 shares, increasing direct ownership by 58% to 24,498 units (SEC Form 4)